Doctor profile · Federal record
Dr. Stefanie Rollins, NP
Nurse Practitioner · Oklahoma City, OK
- NPI 1467780874
- Accepts Medicare
- 17 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
750 Ne 13Th St
Oklahoma City, OK 731045010
(405) 235-0040
fax (405) 272-4028
Credentials & registration
- NPI registered
- November 2009 — 17 yrs on file
- Profile last updated
- February 3, 2014
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Oklahoma #64754
- Medicaid
- OK #200270100A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1467780874. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
572
Distinct HCPCS
6
Medicare allowed
$29,774
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 220 | 167 | $100 | |
95012 |
Test to measure the level of nitric oxide gas | 144 | 90 | $14 | |
94010 |
Test to measure expiratory airflow and volume | 131 | 86 | $21 | |
99211 |
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 29 | 27 | $18 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 27 | 24 | $70 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 21 | 20 | $30 |
In context: peer comparison
Among 31 peers in Oklahoma City Nurse Practitioner, average services per provider: 1,962. This provider delivers 0.3× the peer median.Open Payments
Industry payments received
All-time total
$3,275
Transactions
98
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 21 | $1,101.82 | |
| Regeneron Healthcare Solutions, INC. | 16 | $484.23 | |
| Genzyme Corporation | 16 | $416.48 | |
| Amgen INC. | 17 | $254.17 | |
| Optinose US, INC. | 10 | $238.97 | |
| Genentech, INC. | 2 | $193.43 | |
| GlaxoSmithKline, LLC. | 6 | $178.38 | |
| Regeneron Pharmaceuticals, INC. | 1 | $142.05 | |
| Pharming Healthcare, INC. | 2 | $136.67 | |
| Genentech USA, INC. | 3 | $50.48 | |
| Blueprint Medicines Corporation | 2 | $39.54 | |
| Hologic Sales and Service, LLC | 1 | $22.14 | |
| Novartis Pharmaceuticals Corporation | 1 | $16.69 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
771
Patients
279
Total drug cost
$170,536
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Montelukast Sodium | Generic | 127 | 43 | $4,087 |
| Azelastine Hcl | Generic | 118 | 51 | $5,285 |
| Fluticasone Propionate | Generic | 95 | 42 | $3,707 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 63 | 24 | $49,225 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 49 | 15 | $25,792 |
| Azelastine-Fluticasone (Azelastine/Fluticasone) | Brand | 47 | 18 | $6,429 |
| Levocetirizine Dihydrochloride | Generic | 43 | 20 | $2,066 |
| Ipratropium Bromide | Generic | 40 | 21 | $1,564 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 38 | 0 | $27,326 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 34 | 0 | $17,624 |
Frequently asked questions
What is Dr. Stefanie Rollins's medical specialty?
Dr. Stefanie Rollins practices Nurse Practitioner in Oklahoma City, OK.
Where does Dr. Stefanie Rollins practice?
Dr. Stefanie Rollins practices at 750 Ne 13Th St, Oklahoma City, OK 731045010. Office phone: 4052350040.
What is Dr. Stefanie Rollins's NPI?
Dr. Stefanie Rollins's National Provider Identifier (NPI) is 1467780874, issued by NPPES.
Does Dr. Stefanie Rollins accept Medicare assignment?
Yes. Dr. Stefanie Rollins accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stefanie Rollins commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Test to measure the level of nitric oxide gas (HCPCS 95012); Test to measure expiratory airflow and volume (HCPCS 94010). Source: CMS Medicare Physician & Other Practitioners file.